Filing Details
- Accession Number:
- 0001181431-11-057664
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-28 13:38:09
- Reporting Period:
- 2011-11-23
- Filing Date:
- 2011-11-28
- Accepted Time:
- 2011-11-28 13:38:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1223637 | M Gary Cohen | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-23 | 4,650 | $23.44 | 22,392 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-11-23 | 3,351 | $34.45 | 25,743 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-23 | 8,001 | $89.03 | 17,742 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option Right to Buy | Disposition | 2011-11-23 | 4,650 | $0.00 | 4,650 | $23.44 |
| Common Stock | Director Stock Option Right to Buy | Disposition | 2011-11-23 | 3,351 | $0.00 | 3,351 | $34.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-11-04 | 2017-10-30 | No | 4 | M | Direct |
| 0 | 2009-10-29 | 2018-11-13 | No | 4 | M | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $88.94 to $89.09. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
